BEYOND ANTIEMESIS: EVALUATING INTRAVENOUS DIMENHYDRINATE AS AN ADJUNCT TO CONSCIOUS SEDATION IN IVF OOCYTE RETRIEVALS THROUGH A PROSPECTIVE COHORT STUDY
North American Proceedings in Gynecology and Obstetrics - Supplemental · 26.07.2026 · Suppl (MRSi)
DOI: 10.54053/001c.165543 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift North American Proceedings in Gynecology and Obstetrics - Supplemental, online erschienen am 26.07.2026. Verfasst von M Shere und 6 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
OBJECTIVE: To evaluate the impact of pre-procedural administration of intravenous dimenhydrinate (IV-DMH) on IVF oocyte retrieval pain scores. DESIGN: Prospective cohort study between Jan 1, 2025-Jan 1, 2026. MATERIALS AND METHODS: Patients (n=318) underwent IVF oocyte retrievals at our university-affiliated clinic: 226 patients consented to IV-DMH while 92 declined and were included as controls. All patients and provider-pairs (nurse providing one-on-one support during procedure) completed VAS questionnaires using a pain scale between 1-10 at its “worst” and on “average”. Patient questionnaires examined how the retrieval compared to their expectations (“better”, “similar”, “worse”) and provider questionnaires additionally assessed post-procedure recovery concerns. Descriptive statistics were reported as mean ± standard deviation. Patient VAS pain scores between IV-DMH vs. Controls were compared using unpaired t-tests. Patient experience and adverse effects associated with IV-DMH were characterized as categorical variables and compared using chi-square tests. RESULTS: IVF oocyte retrievals were a “moderately painful” procedure. No statistically significant differences were noted in patient-reported VAS pain scores on “average”, with mean ± standard deviations as follows (5.12 ± 1.71 IV-DMH vs. 4.94 ±1.67 controls). Similarly, there were no differences in patient-reported VAS pain scores during the “worst” part of the procedure (6.86 ± 1.86 IV-DMH vs. 6.73 ±1.76 controls). Provider-perception of patient pain at its “worst” was significantly different compared to patient report (patient 6.94 vs. provider 6.49; p
Zitieren
APA
Shere, M., Deniz, S., Amin, S., Kteily, K., Karnis, M., Neal, M., & Faghih, M. (2026). BEYOND ANTIEMESIS: EVALUATING INTRAVENOUS DIMENHYDRINATE AS AN ADJUNCT TO CONSCIOUS SEDATION IN IVF OOCYTE RETRIEVALS THROUGH A PROSPECTIVE COHORT STUDY. North American Proceedings in Gynecology and Obstetrics - Supplemental, Suppl(MRSi). https://doi.org/10.54053/001c.165543
Vancouver
Shere M, Deniz S, Amin S, Kteily K, Karnis M, Neal M, et al. BEYOND ANTIEMESIS: EVALUATING INTRAVENOUS DIMENHYDRINATE AS AN ADJUNCT TO CONSCIOUS SEDATION IN IVF OOCYTE RETRIEVALS THROUGH A PROSPECTIVE COHORT STUDY. North American Proceedings in Gynecology and Obstetrics - Supplemental. 2026;Suppl(MRSi). doi:10.54053/001c.165543
BibTeX
@article{Shere2026,
author = {Shere, M and Deniz, S and Amin, S and Kteily, K and Karnis, MF and Neal, MS and Faghih, M},
title = {BEYOND ANTIEMESIS: EVALUATING INTRAVENOUS DIMENHYDRINATE AS AN ADJUNCT TO CONSCIOUS SEDATION IN IVF OOCYTE RETRIEVALS THROUGH A PROSPECTIVE COHORT STUDY},
journal = {North American Proceedings in Gynecology and Obstetrics - Supplemental},
year = {2026},
volume = {Suppl},
number = {MRSi},
doi = {10.54053/001c.165543}
}
EUVIMED